These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20132168)

  • 1. Defining the canonical form of T-cell-mediated rejection in human kidney transplants.
    Famulski KS; Einecke G; Sis B; Mengel M; Hidalgo LG; Kaplan B; Halloran PF
    Am J Transplant; 2010 Apr; 10(4):810-820. PubMed ID: 20132168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study.
    Halloran PF; Pereira AB; Chang J; Matas A; Picton M; De Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    Am J Transplant; 2013 Sep; 13(9):2352-63. PubMed ID: 23915426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated Rejection.
    Reeve J; Chang J; Salazar ID; Lopez MM; Halloran PF
    Am J Transplant; 2016 Apr; 16(4):1183-92. PubMed ID: 26730747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relating Molecular T Cell-mediated Rejection Activity in Kidney Transplant Biopsies to Time and to Histologic Tubulitis and Atrophy-fibrosis.
    Madill-Thomsen KS; Böhmig GA; Bromberg J; Einecke G; Eskandary F; Gupta G; Myslak M; Viklicky O; Perkowska-Ptasinska A; Solez K; Halloran PF;
    Transplantation; 2023 May; 107(5):1102-1114. PubMed ID: 36575574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
    Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does tubulitis without interstitial inflammation represent borderline acute T cell mediated rejection?
    Nankivell BJ; P'Ng CH; Chapman JR
    Am J Transplant; 2019 Jan; 19(1):132-144. PubMed ID: 29687946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature of biopsies with "borderline rejection" and prospects for eliminating this category.
    de Freitas DG; Sellarés J; Mengel M; Chang J; Hidalgo LG; Famulski KS; Sis B; Einecke G; Halloran PF
    Am J Transplant; 2012 Jan; 12(1):191-201. PubMed ID: 21992503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessing the Significance of Intimal Arteritis in Kidney Transplant Biopsy Specimens.
    Salazar ID; Merino López M; Chang J; Halloran PF
    J Am Soc Nephrol; 2015 Dec; 26(12):3190-8. PubMed ID: 25918035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of revised criteria for chronic active T cell-mediated rejection in the 2017 Banff classification: Surveillance by 1-year protocol biopsies for kidney transplantation.
    Nakagawa K; Tsuchimoto A; Ueki K; Matsukuma Y; Okabe Y; Masutani K; Unagami K; Kakuta Y; Okumi M; Nakamura M; Nakano T; Tanabe K; Kitazono T;
    Am J Transplant; 2021 Jan; 21(1):174-185. PubMed ID: 32484280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 2-fold Approach to Polyoma Virus (BK) Nephropathy in Kidney Transplants: Distinguishing Direct Virus Effects From Cognate T Cell-mediated Inflammation.
    Halloran PF; Madill-Thomsen KS; Böhmig GA; Myslak M; Gupta G; Kumar D; Viklicky O; Perkowska-Ptasinska A; Famulski KS;
    Transplantation; 2021 Nov; 105(11):2374-2384. PubMed ID: 34310102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bowman capsulitis predicts poor kidney allograft outcome in T cell-mediated rejection.
    Gallan AJ; Chon WJ; Josephson MA; Cunningham PN; Henriksen KJ; Chang A
    Hum Pathol; 2018 Jun; 76():47-51. PubMed ID: 29501487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary metabolomics for noninvasive detection of borderline and acute T cell-mediated rejection in children after kidney transplantation.
    Blydt-Hansen TD; Sharma A; Gibson IW; Mandal R; Wishart DS
    Am J Transplant; 2014 Oct; 14(10):2339-49. PubMed ID: 25138024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of Isolated V1 Arteritis in Renal Transplantation.
    Mikhail D; Chan E; Sharma H; Kleinsteuber D; Wei J; Rim C; Henein M; Sener A; Jevnikar AM; Gabril M; Moussa M; Luke PP
    Transplant Proc; 2021 Jun; 53(5):1570-1575. PubMed ID: 33994184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Histological Spectrum and Clinical Significance of T Cell-mediated Rejection of Kidney Allografts.
    Filippone EJ; Farber JL
    Transplantation; 2023 May; 107(5):1042-1055. PubMed ID: 36584369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell mediated rejection revisited: Past, current, and future directions.
    Hara S
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():45-51. PubMed ID: 29968416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular phenotype of kidney transplant indication biopsies with inflammation in scarred areas.
    Halloran PF; Matas A; Kasiske BL; Madill-Thomsen KS; Mackova M; Famulski KS
    Am J Transplant; 2019 May; 19(5):1356-1370. PubMed ID: 30417539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular landscape of T cell-mediated rejection in human kidney transplants: prominence of CTLA4 and PD ligands.
    Venner JM; Famulski KS; Badr D; Hidalgo LG; Chang J; Halloran PF
    Am J Transplant; 2014 Nov; 14(11):2565-76. PubMed ID: 25219326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies.
    Reeve J; Sellarés J; Mengel M; Sis B; Skene A; Hidalgo L; de Freitas DG; Famulski KS; Halloran PF
    Am J Transplant; 2013 Mar; 13(3):645-55. PubMed ID: 23356949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early surveillance biopsy utilization and management of pediatric renal allograft acute T cell-mediated rejection in Canadian centers: Observations from the PROBE multicenter cohort study.
    Hoffmann AJ; Gibson IW; Ho J; Nickerson P; Rush D; Sharma A; Wishart D; Blydt-Hansen TD
    Pediatr Transplant; 2021 Mar; 25(2):e13870. PubMed ID: 33026135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.
    Loupy A; Haas M; Solez K; Racusen L; Glotz D; Seron D; Nankivell BJ; Colvin RB; Afrouzian M; Akalin E; Alachkar N; Bagnasco S; Becker JU; Cornell L; Drachenberg C; Dragun D; de Kort H; Gibson IW; Kraus ES; Lefaucheur C; Legendre C; Liapis H; Muthukumar T; Nickeleit V; Orandi B; Park W; Rabant M; Randhawa P; Reed EF; Roufosse C; Seshan SV; Sis B; Singh HK; Schinstock C; Tambur A; Zeevi A; Mengel M
    Am J Transplant; 2017 Jan; 17(1):28-41. PubMed ID: 27862883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.